Prognosis value of positron emission tomography using F18-fluorodeoxyglucose (FDG-PET) in the setting of ASCT in patients with high grade non-Hodgkin lymphoma (HGNHL).

被引：0
|
作者：
Bodet-Milin, C.
Rolland, V.
Oudoux, A.
Aansquer, C.
Le Goille, S.
Valette, F.
Rousseau, C.
Dupas, B.
Moreau, P.
Harrousseau, J.
Kraeber-Bodere, F.
机构：
[1] Univ Hosp, Nantes, France
[2] Ctr Canc, Nantes, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [31] The role of positron emission tomography scan with 18F-fluorodeoxyglucose (FDG-PET) as the chief predictor of autologous stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma.
    Caroli, P.
    Fantini, L.
    Ambrosini, V.
    Lopci, E.
    Musto, A.
    Maffione, A.
    Golemi, A.
    Santi, I.
    Fuccio, C.
    Tsamita, C.
    Derenzini, E.
    Zinzani, P.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S335 - S336
  • [32] Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck:: is it likely to be superior?
    Brouwer, J
    de Bree, R
    Comans, EFI
    Castelijns, JA
    Hoekstra, OS
    Leemans, CR
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2004, 261 (09) : 479 - 483
  • [33] Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?
    Jolijn Brouwer
    Remco de Bree
    Emile F. I. Comans
    Jonas A. Castelijns
    Otto S. Hoekstra
    C. René Leemans
    European Archives of Oto-Rhino-Laryngology and Head & Neck, 2004, 261 : 479 - 483
  • [34] Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma
    Blum, RH
    Seymour, JF
    Wirth, A
    MacManus, M
    Hicks, RJ
    CLINICAL LYMPHOMA, 2003, 4 (01): : 43 - 49
  • [35] Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma
    Spaepen, K
    Stroobants, S
    Dupont, P
    Vandenberghe, P
    Thomas, J
    de Groot, T
    Balzarini, J
    De Wolf-Peeters, C
    Mortelmans, L
    Verhoef, G
    ANNALS OF ONCOLOGY, 2002, 13 (09) : 1356 - 1363
  • [36] Positron emission tomography with 18F-FLT and 18F-FDG for staging and grading of non-Hodgkin's lymphoma
    Buck, AK
    Schirrmeister, H
    Bommer, M
    Tepsic, D
    Glatting, G
    Vogg, ATJ
    Neumaier, B
    Wahl, A
    Blumstein, NM
    Mottaghy, F
    Krause, BJ
    Reske, SN
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S338 - S338
  • [37] 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer
    Alberini, Jean-Louis
    Lerebours, Florence
    Wartski, Myriam
    Fourme, Emmanuelle
    Le Stanc, Elise
    Gontier, E.
    Madar, O.
    Cherel, P.
    Pecking, A. P.
    CANCER, 2009, 115 (21) : 5038 - 5047
  • [38] 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Maximum Standardized Uptake Value (SUVmax) as a Prognostic Factor in Adult Hodgkin Lymphoma Patients
    Adli, M.
    Caglayan, D.
    Koc, M.
    Zincirkeser, S.
    Turk, H. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S552 - S553
  • [39] Preliminary results of positron emission tomography with F18-fluorodeoxyglucose (FDG-PET) in initial staging and treatment assessment of patients with peripheral T-cell lymphomas (PTCL).
    Bodet-Milin, C.
    Rolland, V.
    Oudoux, A.
    Aansquer, C.
    Le Guoill, S.
    Valette, F.
    Rousseau, C.
    Dupas, B.
    Moreau, P.
    Harousseau, J.
    Kraeber-Bodere, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S257 - S257
  • [40] Pre-transplant fluorodeoxyglucose positron emission tomography (FDG-PET) scanning as a predictor of autologous stem cell transplantation (ASCT) outcome in aggressive non Hodgkin lymphoma (NHL)
    Derenzini, E.
    Musuraca, G.
    Stefoni, V
    Marchi, E.
    Alinari, L.
    Fina, M.
    Tani, M.
    Pellegrini, C.
    Fanti, S.
    Zinzani, P. L.
    Baccarani, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 47 - 47
12345